Fennec Pharmaceuticals (FENC) Enterprise Value (QoQ) (2010 - 2025)
Fennec Pharmaceuticals (FENC) Enterprise Value (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 296.63 Mn | 259.84 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -67.62% |
| Sep 30, 2025 | -17.33% |
| Jun 30, 2025 | 17.51% |
| Mar 31, 2025 | 14.86% |
| Dec 31, 2024 | 33.94% |
| Sep 30, 2024 | 6.35% |
| Jun 30, 2024 | 15.88% |
| Mar 31, 2024 | -285.74% |
| Dec 31, 2023 | -7.02% |
| Sep 30, 2023 | 17.11% |
| Jun 30, 2023 | -12.73% |
| Mar 31, 2023 | 44.19% |
| Dec 31, 2022 | 20.09% |
| Sep 30, 2022 | -99.48% |
| Jun 30, 2022 | 18.31% |
| Mar 31, 2022 | 13.46% |
| Dec 31, 2021 | 13.29% |
| Sep 30, 2021 | 10.84% |
| Jun 30, 2021 | -2.03% |
| Mar 31, 2021 | 11.84% |